z-logo
open-access-imgOpen Access
Neoplasms reported with liraglutide or placebo in people with type 2 diabetes: Results from the LEADER randomized trial
Author(s) -
M.A. Nauck,
T.J. Jensen,
C. Rosenkilde,
S. Calanna,
J.B. Buse
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/t29z-8831
Subject(s) - liraglutide , type 2 diabetes , randomized controlled trial , placebo , medicine , diabetes mellitus , physical therapy , endocrinology , alternative medicine , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom